Linkage analysis of factor VIII and von Willebrand factor loci as quantitative trait loci

被引:26
作者
De Visser, MCH
Sandkuijl, LA
Lensen, RPM
Vos, JL
Rosendaal, FR
Bertina, RM
机构
[1] Leiden Univ, Med Ctr, Dept Hematol, Ctr Hemostasis & Thrombosis Res, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands
关键词
ABO blood group; factor VIII; quantitative trait loci; von Willebrand factor;
D O I
10.1046/j.1538-7836.2003.00314.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Elevated factor (F)VIII levels contribute to venous thrombotic risk. FVIII levels are determined to a large extent by levels of von Willebrand factor (VWF), its carrier protein which protects FVIII against proteolysis. VWF levels are largely dependent on ABO blood group. Subjects with blood group non-O have higher VWF and FVIII levels than individuals with blood group O. Apart from ABO blood group no genetic determinants of high FVIII levels have been identified, whereas clustering of FVIII levels has been reported within families even after adjustment for ABO blood group and VWF levels. We investigated the FVIII and VWF loci as possible quantitative trait loci (QTL) influencing FVIII and VWF levels. Two sequence repeats in the FVIII gene and three repeats in the VWF gene were typed in 52 FV Leiden families. Multipoint sib-pair linkage analysis was performed with the MAPMAKER/SIBS program. FVIII levels adjusted for VWF levels and age, and VWF levels adjusted for ABO blood group and age, were used for this linkage analysis. No linkage of FVIII levels to the FVIII locus was found, whereas we found evidence that the VWF locus contains a QTL for VWF levels [maximum likelihood no dominance variance lod score = 0.70 (P = 0.04) and non-parametric Z-score = 1.92 (P = 0.03)]. About 20% of the total variation in VWF levels may be attributed to this VWF locus.
引用
收藏
页码:1771 / 1776
页数:6
相关论文
共 48 条
[1]   Molecular genetics of coagulation factor VIII gene and haemophilia A [J].
Antonarakis, SE .
HAEMOPHILIA, 1998, 4 :1-11
[2]   High concentrations of coagulation factor VIII and thrombosis: is the factor VIII-binding domain of von Willebrand factor implicated? [J].
Bowen, DJ ;
Maclean, RM ;
Pellard, S ;
Collins, PW .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (03) :655-657
[3]   PURIFIED HUMAN FACTOR-VIII PROCOAGULANT PROTEIN - COMPARATIVE HEMOSTATIC RESPONSE AFTER INFUSIONS INTO HEMOPHILIC AND VONWILLEBRAND DISEASE DOGS [J].
BRINKHOUS, KM ;
SANDBERG, H ;
GARRIS, JB ;
MATTSSON, C ;
PALM, M ;
GRIGGS, T ;
READ, MS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (24) :8752-8756
[5]   GENETIC-VARIATION AT THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 LOCUS IS ASSOCIATED WITH ALTERED LEVELS OF PLASMA PLASMINOGEN-ACTIVATOR INHIBITOR-1 ACTIVITY [J].
DAWSON, S ;
HAMSTEN, A ;
WIMAN, B ;
HENNEY, A ;
HUMPHRIES, S .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (01) :183-190
[6]   The genetics of haemostasis:: a twin study [J].
de Lange, M ;
Snieder, H ;
Ariëns, RAS ;
Spector, TD ;
Grant, PJ .
LANCET, 2001, 357 (9250) :101-105
[7]   Prospective study of hemostatic factors and incidence of coronary heart disease - The Atherosclerosis Risk in Communities (ARIC) Study [J].
Folsom, AR ;
Wu, KK ;
Rosamond, WD ;
Sharrett, AR ;
Chambless, LE .
CIRCULATION, 1997, 96 (04) :1102-1108
[8]   Prospective study of markers of hemostatic function with risk of ischemic stroke [J].
Folsom, AR ;
Rosamond, WD ;
Shahar, E ;
Cooper, LS ;
Aleksic, N ;
Nieto, FJ ;
Rasmussen, ML ;
Wu, KK .
CIRCULATION, 1999, 100 (07) :736-742
[9]  
Franco RF, 2001, HAEMATOLOGICA, V86, P510
[10]  
GILL JC, 1987, BLOOD, V69, P1691